mlsanityData to 7 Oct 2026

DeepScaffold: a comprehensive tool for scaffold-based de novo drug discovery using deep learning

arXiv 1908.07209 ↗First posted 20 Aug 2019q-bio.QM cs.LGcited by 15

Not on the map. Why?

Abstract (arXiv)

The ultimate goal of drug design is to find novel compounds with desirable pharmacological properties. Designing molecules retaining particular scaffolds as the core structures of the molecules is one of the efficient ways to obtain potential drug candidates with desirable properties. We proposed a scaffold-based molecular generative model for scaffold-based drug discovery, which performs molecule generation based on a wide spectrum of scaffold definitions, including BM-scaffolds, cyclic skeletons, as well as scaffolds with specifications on side-chain properties. The model can generalize the learned chemical rules of adding atoms and bonds to a given scaffold. Furthermore, the generated compounds were evaluated by molecular docking in DRD2 targets and the results demonstrated that this approach can be effectively applied to solve several drug design problems, including the generation of compounds containing a given scaffold and de novo drug design of potential drug candidates with specific docking scores. Finally, a command line interface is created.

Key facts. Cited by 15 papers in the map (data through 7 Oct 2026). First posted on arXiv 20 Aug 2019.

Builds on

No reference list yet.

Built on by

Cited by year

Citing papers per year: 2021: 4; 2022: 2; 2023: 3; 2024: 4; 2025: 2.

15 papers.

Sort:

By area: